AnalystsWhitney IjemWhitney Ijem's Stock Forecasts
AnalystsWhitney Ijem
Sectors:
Industries:
Analyst Ranking
Top 8%
#304 out of 4233 analysts
Average Return
+30.35%
Win Rate
32%6 out of 19
Risk vs Reward
Poor
Good
Whitney Ijem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcturus Therapeutics Holdings IncARCT | +606.98% | $12.03 | $85.05 | 2020-02-06 - 2021-02-05 | Strong Buy |
Tenaya Therapeutics IncTNYA | +295.60% | $1.82 | $7.20 | 2022-11-07 - 2023-05-31 | Strong Buy |
Neubase Therapeutics IncNBSE | +71.82% | $6.28 | $10.79 | 2020-02-06 - 2021-02-05 | Strong Buy |
Rocket Pharmaceuticals IncRCKT | +29.68% | $16.14 | $20.93 | 2022-11-07 - 2023-05-31 | Strong Buy |
Ultragenyx Pharmaceutical IncRARE | +15.81% | $42.62 | $49.36 | 2023-01-17 - 2023-05-31 | Strong Buy |
Whitney Ijem Analyst Color
Get additional color on Whitney Ijem's coverage of popular stocks
Whitney Ijem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intellia Therapeutics IncNTLA | 1 | Strong Buy | $66.00 | +77.13% | Initiates Coverage On | 2 months ago |
Verve Therapeutics IncVERV | 1 | Strong Buy | $29.00 | +87.34% | Initiates Coverage On | 2 months ago |
Rhythm Pharmaceuticals IncRYTM | 1 | Strong Buy | $56.00 | +236.13% | Maintains | 3 months ago |
Biomarin Pharmaceutical IncBMRN | 2 | Hold | $112.00 | +28.82% | Maintains | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $291.00 | +57.29% | Maintains | 3 months ago |
Taysha Gene Therapies IncTSHA | 2 | Strong Buy | $13.00 | +1,759.80% | Maintains | 4 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Hold | $311.00 | -3.88% | Initiates Coverage On | 4 months ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Strong Buy | $90.00 | +82.33% | Assumes | 4 months ago |
Sigilon Therapeutics IncSGTX | 1 | Strong Buy | $78.00 | +1,757.14% | Initiates Coverage On | 4 months ago |
Passage Bio IncPASG | 1 | Strong Buy | $8.00 | +741.22% | Initiates Coverage On | 7 months ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Buy | $53.00 | +153.23% | Initiates Coverage On | 7 months ago |
Generation Bio CoGBIO | 1 | Strong Buy | $9.00 | +157.14% | Initiates Coverage On | 7 months ago |
Regulus Therapeutics IncRGLS | 1 | Strong Buy | $9.00 | +592.31% | Initiates Coverage On | 7 months ago |
Tenaya Therapeutics IncTNYA | 1 | Strong Buy | $21.00 | +191.67% | Initiates Coverage On | 7 months ago |
Neubase Therapeutics IncNBSE | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 3 years ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 3 years ago |
Karyopharm Therapeutics IncKPTI | 3 | Hold | $7.00 | N/A | Downgrades | 4 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.